Abstract

Cysteamine Hydrochloride 100 mg/mL Oral Solution

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2022 - Volume 26, Number 5

Page(s): 427

Download in electronic PDF format for $75
  • Cysteamine Hydrochloride 100 mg/mL Oral Solution Page 1

Abstract

A formulation for preparing Cysteamine Hydrochloride 100 mg/mL Oral Solution. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • cysteamine hydrochloride
  • formulation
  • nutritional supplement
  • corneal cystine crystal accumulation
  • cystinosis
  • eye disorders
  • orphan drug

Related Categories

  • FORMULATIONS
  • NUTRITION AND NUTRICEUTICALS
  • OPHTHALMICS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2022
Pg. 427
Cysteamine Hydrochloride 100 mg/mL Oral Solution
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 408
Cysteamine 0.5% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Nov/Dec 2015
Pg. 505
Cefepime Hydrochloride 100-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 250
Thiamine Hydrochloride 100-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Sep/Oct 2003
Pg. 389-393
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Author(s): Alexander Kenneth S, Thyangarajapuram N
May/Jun 2020
Pg. 252-262
Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, Loures da Silva Sharlene, Neves Cunha Carolina, de Oliveira Ferreira Anderson, Anagnostou Korina, Dijkers Eli
Jul/Aug 2011
Pg. 308-315
Transdermals: The Skin as Part of a Drug Delivery System
Author(s): Allen Loyd V Jr
Nov/Dec 2013
Pg. 502
Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Mar/Apr 2015
Pg. 148
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 505
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2014
Pg. 68
Procainamide Hydrochloride 100-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 149
Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2010
Pg. 512
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 414
Levocarnitine 100-mg/mL Oral Solution
Author(s): Allen Loyd V Jr
Jul/Aug 2002
Pg. 288-292
Basics of Compounding for Iontophoresis, Part II
Author(s): Allen Loyd V Jr
Jul/Aug 2002
Pg. 311-315
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs
Author(s): Trissel Lawrence A, Saenz Christopher